Stock listing

EKTABS Stock Price, News, Filings & Events — Elekta Ab Class B

Selected listing: EKTABS · AQUISEU · SEK · GB

This page tracks Elekta Ab Class B's EKTABS:AQUISEU listing on AQUISEU in SEK for GB, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following EKTABS:AQUISEU. EKTABS:AQUISEU is the stock-level entry point for investors researching Elekta Ab Class B, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Elekta Ab Class B is a publicly traded company on the Swedish market, with a market capitalization of approximately 1.78 billion USD. The company specializes in innovative solutions for cancer treatment and brain disorders. Elekta aims to improve patient outcomes through advanced technology and personalized care.

EKTABS:AQUISEUSEKGBUpdated August 22, 2026
Elekta Ab Class B logo
Ticker
EKTABS:AQUISEU
Asset type
Stock
Market cap
$2.22B
Sector
Health Technology
Industry
Medical Specialties
Exchange
AQUISEU
Currency
SEK

Elekta Ab Class B EKTABS:AQUISEU stock context

This page tracks Elekta Ab Class B's EKTABS:AQUISEU listing on AQUISEU in SEK for GB, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following EKTABS:AQUISEU. EKTABS:AQUISEU is the stock-level entry point for investors researching Elekta Ab Class B, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Elekta Ab Class B is a publicly traded company on the Swedish market, with a market capitalization of approximately 1.78 billion USD. The company specializes in innovative solutions for cancer treatment and brain disorders. Elekta aims to improve patient outcomes through advanced technology and personalized care.

Latest news from Elekta Ab Class B

All Elekta Ab Class B news →

Elekta Ab Class B earnings calls

Research Elekta Ab Class B

Alternate listings